InvestorsHub Logo

Monk44

11/12/21 10:10 AM

#43283 RE: changes_iv #43282

"Doctors at the Freiburg University Medical Centre have come up with a novel therapeutic approach involving the intestinal hormone VIP (vasoactive intestinal peptide), which was given by way of inhalation to a patient who had developed pneumonia as a consequence of immune therapy."


Can we assume that this is Aviptadil in our inhaler?
Inhaled VIP is not available anywhere else, corect?